pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
DROSPIRENONE AND ETHINYL ESTRADIOL
DROSPIRENONE AND ETHINYL ESTRADIOL (DROSPIRENONE AND ETHINYL ESTRADIOL)
GLENMARK PHARMS LTD
0 catalysts
Phase 2
DS-01
Irritable Bowel Syndrome
Seed Health Inc
0 catalysts
Phase 1
DS-1103
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Integral Molecular Inc
0 catalysts
Phase 1
DS-2243
Solid Tumor
← prev
page 86 of 271
next →
131
Pain89
Neurology1
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
DS-3939
Solid Tumor
Daiichi Sankyo Co Ltd
0 catalysts
Phase 1
DS-5361
Head And Neck Squamous Cell Carcinoma (HNSC)
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
DS-7011
Cutaneous Lupus Erythematosus
Daiichi Sankyo Co Ltd
0 catalysts
Phase 1
DS-9051
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
DSG3-CAART
Pemphigus Vulgaris
$CABACabaletta Bio, Inc.
0 catalysts
Phase 1
DSP-0038
Alzheimer's Disease
Sumitomo Pharma America Inc
0 catalysts
Phase 2
DSP-107
Colorectal Cancer
KAHR medical Ltd
0 catalysts
Phase 1
DSP-2342
Unspecified Psychiatric Disorders
Sumitomo Pharma America Inc
0 catalysts
Phase 2
DSP-3077
Retinitis Pigmentosa (Retinitis)
Sumitomo Pharma Co Ltd
0 catalysts
Phase 1
DSP-3456
Treatment Resistant Depression
Sumitomo Pharma Co Ltd
0 catalysts
Phase 1
DST-2105
Keratoconjunctivitis Sicca (Dry Eye)
DelSiTech Ltd
0 catalysts
Preclinical
DT-003
Open-Angle Glaucoma
Diorasis Therapeutics
0 catalysts
Phase 2
DT-101
Major Depressive Disorder
Draig Therapeutics Ltd
0 catalysts
Phase 2
DT-168
Fuchs Endothelial Corneal Dystrophy (FECD)
Metabotropic glutamate receptor 4
$DSGNDesign Therapeutics, Inc.
0 catalysts
Preclinical
DTI-117
Urinary Retention
Dignify Therapeutics LLC
0 catalysts
Preclinical
DTI-301
Constipation
Dignify Therapeutics LLC
0 catalysts
Preclinical
DUET-101
Bladder Cancer
Duet Therapeutics Inc
0 catalysts
DULOXETINE
DULOXETINE (DULOXETINE)
INVENTIA
0 catalysts
DULOXETINE HYDROCHLORIDE
DULOXETINE HYDROCHLORIDE (DULOXETINE HYDROCHLORIDE)
Alembic Pharmaceuticals Inc
0 catalysts
DUOPA
DUOPA (CARBIDOPA)
1 INDICATIONS AND USAGE DUOPA ® is indicated for the treatment of motor fluct…
Aromatic-L-amino-acid decarboxylase
$ABBVAbbVie Inc.
0 catalysts
DUPIXENT
DUPIXENT (DUPILUMAB)
1 INDICATIONS AND USAGE DUPIXENT is an interleukin-4 receptor alpha antagonis…
Interleukin-4 receptor subunit alpha
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
DURAMORPH PF
DURAMORPH PF (MORPHINE SULFATE)
Hikma Pharmaceuticals Plc
0 catalysts
DUREZOL
DUREZOL (DIFLUPREDNATE)
Sandoz Inc
0 catalysts
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE (DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE)
AUROBINDO PHARMA
0 catalysts
Phase 1
DVX-201
Myelodysplastic Syndrome (Preleukemia)
$COEPCoeptis Therapeutics Holdings, Inc.
0 catalysts
Phase 2
DX-126262
Gastric Cancer
Hangzhou DAC Biotech Co Ltd
0 catalysts